What happens if I only receive 1 dose of the Shingrix (herpes zoster vaccine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effectiveness of a Single Dose of Shingrix (Herpes Zoster Vaccine)

Receiving only one dose of Shingrix provides significantly less protection against shingles than the complete two-dose series, with single-dose effectiveness of approximately 57% compared to 70% with two doses. 1

Effectiveness of Single vs. Complete Dosing

  • A large real-world observational study found that one dose of Shingrix provides approximately 56.9% effectiveness against herpes zoster, while completing the two-dose regimen increases effectiveness to 70.1% 1
  • The complete two-dose series is strongly recommended for optimal protection against shingles and its complications 2
  • Clinical trials demonstrated that the two-dose regimen of Shingrix provides over 90% efficacy in preventing herpes zoster in adults aged 50 years and older 3

Completion Rates and Timing

  • Among people who receive a first dose of Shingrix, approximately 70% complete the two-dose series within six months, and 80% complete it within 12 months 4
  • The recommended schedule for Shingrix is two doses administered 2-6 months apart 3
  • Importantly, second doses administered beyond the recommended 6-month window still provide effective protection, so patients should be encouraged to complete the series even if delayed 1

Special Populations

  • For immunocompromised adults aged ≥18 years, the second dose can be given 1-2 months after the first dose if they would benefit from a shorter vaccination schedule 2
  • The two-dose effectiveness was not significantly lower for adults aged >80 years or for individuals with autoimmune conditions 1
  • The vaccine remains effective among individuals with immunosuppressive conditions, though a complete two-dose series is particularly important for optimal protection in these populations 1

Barriers to Completion

  • Concerns about vaccine tolerability are significantly associated with failure to complete the two-dose series 5
  • Individuals concerned about side effects are 1.83 times more likely to receive only one dose rather than completing the full two-dose series 5
  • Common side effects include injection-site reactions (pain, redness, swelling) and systemic symptoms, which are generally temporary 3

Clinical Recommendations

  • If you've only received one dose of Shingrix, you should get the second dose as soon as possible, even if more than 6 months have passed since the first dose 1
  • There is no need to restart the vaccination series if the interval between doses is longer than recommended 3
  • Protection against shingles persists for at least 8 years with minimal waning when the complete two-dose series is administered 3

Prevention of Complications

  • The two-dose regimen provides 76% effectiveness against postherpetic neuralgia, one of the most debilitating complications of shingles 1
  • Without the second dose, you may have inadequate protection against both shingles and its potential complications 2, 1

References

Research

Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Guideline

Timing of Shingles Vaccination After a Shingles Outbreak

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SHINGRIX Vaccination Schedule for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.